QTRX Stock Analysis: Buy, Sell, or Hold?
QTRX - Quanterix Corporation Common Stock
$3.53
0.31 (9.63%)
▲
5d:
+15.36%
30d:
+31.23%
90d:
-7.59%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When QTRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: QTRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: QTRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: QTRX is currently trading at $3.53, which is considered extended relative to its 30-day fair value range of $2.70 to $3.42.
Technical Outlook: Technically, QTRX is in a strong downtrend. Immediate support is located at $2.58, while resistance sits at $4.03. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: QTRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+34.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QTRX is in a strong downtrend. Immediate support is located at $2.58, while resistance sits at $4.03. The stock is showing strong short-term momentum, up 9.6% recently.
Market Sentiment: QTRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+34.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.70 -
$3.42
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.6%)
- BULLISH: Trading 34.6% below Wall St target ($4.33)
Trading Range Analysis
30-Day Trading Range
$2.70 -
$3.42
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.59
Resistance Level
$4.03
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.37
Wall Street Target
$4.33
(+34.6%)
Revenue Growth (YoY)
20.1%
Profit Margin
-71.9%
Share & Embed Analysis
Last updated: June 24, 2026 11:12 AM ET
Data refreshes hourly during market hours. Next update: 12:12 PM
Data refreshes hourly during market hours. Next update: 12:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
